Fabien Gaire

3.2k total citations
11 papers, 200 citations indexed

About

Fabien Gaire is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Fabien Gaire has authored 11 papers receiving a total of 200 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 5 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Molecular Biology. Recurrent topics in Fabien Gaire's work include Radiomics and Machine Learning in Medical Imaging (4 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Advanced Biosensing Techniques and Applications (2 papers). Fabien Gaire is often cited by papers focused on Radiomics and Machine Learning in Medical Imaging (4 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Advanced Biosensing Techniques and Applications (2 papers). Fabien Gaire collaborates with scholars based in Germany, Switzerland and United States. Fabien Gaire's co-authors include Murry W. Wynes, Fred R. Hirsch, Beatrice Hauss‐Wegrzyniak, Masafumi Kurosumi, James Pettay, Margaret Loftus, Thomas M. Grogan, Konstanty Korski, Raymond R. Tubbs and Lin Wang and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and Annals of Oncology.

In The Last Decade

Fabien Gaire

10 papers receiving 196 citations

Peers

Fabien Gaire
Jürgen Wolf Germany
Donna C. Ferguson United States
Fatma Althoubaity Saudi Arabia
Fabien Gaire
Citations per year, relative to Fabien Gaire Fabien Gaire (= 1×) peers Dina Sakaeva

Countries citing papers authored by Fabien Gaire

Since Specialization
Citations

This map shows the geographic impact of Fabien Gaire's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fabien Gaire with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fabien Gaire more than expected).

Fields of papers citing papers by Fabien Gaire

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fabien Gaire. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fabien Gaire. The network helps show where Fabien Gaire may publish in the future.

Co-authorship network of co-authors of Fabien Gaire

This figure shows the co-authorship network connecting the top 25 collaborators of Fabien Gaire. A scholar is included among the top collaborators of Fabien Gaire based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fabien Gaire. Fabien Gaire is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Brennan, Laura, Jurriaan Brouwer‐Visser, Eveline Nüesch, et al.. (2022). T-Cell Heterogeneity in Baseline Tumor Samples: Implications for Early Clinical Trial Design and Analysis. Frontiers in Immunology. 13. 760763–760763. 2 indexed citations
2.
Abbasi-Sureshjani, Samaneh, et al.. (2021). Molecular Subtype Prediction for Breast Cancer Using H&E Specialized Backbone. 1–9. 2 indexed citations
3.
Failmezger, Henrik, Chia-Huey Ooi, Derrek P. Hibar, et al.. (2020). Analysis of Spatial Organization of Suppressive Myeloid Cells and Effector T Cells in Colorectal Cancer—A Potential Tool for Discovering Prognostic Biomarkers in Clinical Research. Frontiers in Immunology. 11. 550250–550250. 18 indexed citations
5.
Korski, Konstanty, et al.. (2019). Prediction of biomarker status, diagnosis and outcome from histology slides using deep learning-based hypothesis free feature extraction.. Journal of Clinical Oncology. 37(15_suppl). 3140–3140. 2 indexed citations
6.
Schwen, Lars Ole, Emilia Andersson, Konstanty Korski, et al.. (2018). Data-Driven Discovery of Immune Contexture Biomarkers. Frontiers in Oncology. 8. 627–627. 20 indexed citations
7.
Cañamero, Marta, Konstanty Korski, Oliver Grimm, et al.. (2016). Abstract B47: Unraveling tumor metabolism with in silico IHC multiplexing supported by automated imaging analysis. Molecular Cancer Research. 14(1_Supplement). B47–B47. 1 indexed citations
8.
Mascaux, Céline, Murry W. Wynes, Yasufumi Kato, et al.. (2011). EGFR Protein Expression in Non–Small Cell Lung Cancer Predicts Response to an EGFR Tyrosine Kinase Inhibitor—A Novel Antibody for Immunohistochemistry or AQUA Technology. Clinical Cancer Research. 17(24). 7796–7807. 29 indexed citations
9.
Badzio, A., Murry W. Wynes, Rafał Dziadziuszko, et al.. (2010). Increased Insulin-Like Growth Factor 1 Receptor Protein Expression and Gene Copy Number in Small Cell Lung Cancer. Journal of Thoracic Oncology. 5(12). 1905–1911. 47 indexed citations
11.
Nitta, Hiroaki, Beatrice Hauss‐Wegrzyniak, Fabien Gaire, et al.. (2008). Development of automated brightfield HER2 and chromosome 17 centromere (CEN17) double in situ hybridization application for breast carcinomas and its performance comparison to manual HER2 fluorescence in situ hybridization (FISH). Journal of Clinical Oncology. 26(15_suppl). 11080–11080. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026